Bob Hopkins is a Senior Analyst and Managing Director in the US equity research group at Bank of America Merrill Lynch (BofAML). Since joining BofAML in July of 2008, he has served as head of the firm’s medical technology equity research group covering both large and mid-cap stocks within the cardiovascular, orthopedics, and general medical supply spaces. For the last 12 years Bob has been ranked as one of the top medical device analyst in the US as per the annual Institutional Investor Magazine’s poll, which surveys the largest institutional money managers and hedge funds each year to assess which sell side analysts add the most value. Before joining BofAML, Bob followed the medical device space starting in 1997 at DLJ and later with Lehman Brothers until July 2008 when he joined Bank of America. Bob’s coverage list includes Abbott, Baxter, Boston Scientific, Cardiovascular Systems, CR Bard, Edwards, Entellus, Glaukos, Globus, Hill-Rom, Intersect ENT, Intuitive Surgical, J&J, Medtronic, Nevro, NuVasive, Penumbra, Stryker, Tandem, and Zimmer.
Bob graduated from Trinity College in Hartford, CT in 1989 and received his MBA from Columbia University in NY in 1995. Bob has built up a strong reputation for his long standing clinical contacts, his independent research and his industry knowledge. His phone number in NY is 646-855-3131 and his email address is [email protected]